![](https://canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBjQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--fd8fc7993fb53aab3fcece2b0a6ba373a7498ef4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Atheromed.jpg)
AtheroMed
AtheroMed is developing world-class treatments for Peripheral Arterial Disease, a common circulatory problem in which narrowed arteries reduce the blood flow to your limbs.
Investment
Series A
AtheroMed is developing world-class treatments for Peripheral Arterial Disease, a common circulatory problem in which narrowed arteries reduce the blood flow to your limbs.
Series A